Clinical Trials
3 trialsNCT06352502 2024-04-08
An Observational Study of Furmonertinib for EGFR Mutation-positive NSCLC Patients With Brain Metastasis
Tang-Du Hospital
Unknown
NCT03749213 2018-11-21
Icotinib as Neoadjuvant Therapy in EGFR-mutant Stage â…¢A-N2 Non-small Cell Lung Cancer
Betta Pharmaceuticals Co., Ltd.
Phase 2 Unknown
NCT03349203 2018-07-18
Icotinib as Neoadjuvant and Adjuvant Therapy in EGFR-mutant Stage IIIB or Oligometastasis Non-small Cell Lung Cancer
Betta Pharmaceuticals Co., Ltd.
Phase 2 Unknown